Our vision: A world free of Lyme and other tick-borne diseases.
Global Lyme Alliance (GLA) is the leading 501(c)(3) whose mission is to cure Lyme and other tick-borne diseases through innovation research, awareness, and empowering the patient voice.
We find and support researchers who think outside the box regarding diagnostic tests, cutting edge pharmaceuticals, as well as holistic treatment protocols. We connect Lyme specialist physicians with each other and with researchers to better understand the clinical features of patients suffering from chronic Lyme disease and other tick-borne co-infections. We also connect patients in our community with healthcare practitioners familiar with Lyme disease and provide a free peer-to-peer mentor support program for those in need.
The CDC estimates that there are approximately 476,000 Lyme disease cases each year in the United States. It is likely that cases will continue to rise. We are all one tick bite away from dealing with the potentially devastating effects of Lyme disease and other vector-borne infections. Currently, the gold- standard FDA-approved CDC two-tiered test is less than 60% accurate at detecting early Lyme disease. In addition, 10-20% of Lyme patients still suffer from symptoms after standard-of- care antibiotic treatment. Lyme can develop into a chronic illness that leads to serious health problems and reduced quality of life, so the discovery of alternative therapeutics is vital to help those battling the disease.
OUR MISSION:
Cure Lyme and other tick-borne diseases through innovative research, awareness, and empowering the patient voice.
